MED-EL ELEKTROMEDIZINISCHE GERAETE GmbH

MED-EL is a global leader in hearing implant technology, headquartered in Innsbruck, Austria. The company manufactures and distributes a comprehensive portfolio of implantable and non-implantable hearing solutions designed for conductive, mixed, and sensorineural hearing loss across all severity levels. Founded in the late 1980s by Ingeborg and Erwin Hochmair, MED-EL operates 30+ subsidiaries and serves over 4,000 clinics in 124 countries, with more than 95% of implants exported internationally. The company pioneered multi-channel cochlear implants and Electric Acoustic Stimulation (EAS) technology. Core product lines include cochlear implant systems (SYNCHRONY 2), middle ear implants (VIBRANT SOUNDBRIDGE), bone conduction implants (BONEBRIDGE), non-surgical bone conduction devices (ADHEAR), and audio processors (RONDO 3, SONNET 3, SAMBA 2). MED-EL serves both adult and pediatric patients, offering wireless connectivity options and remote care capabilities through the HearCare app.